Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2024 - 2025)
Baird Medical Investment Holdings (BDMD) posted quarterly Non-Current Deferred Tax Liability of $21559.0 for Q2 2025, down 52.34% quarter-over-quarter from $45238.0 in Q4 2024.
Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2024 - 2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has reported Non-Current Deferred Tax Liability for 2 consecutive years, with $21559.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Non-Current Deferred Tax Liability changed N/A year-over-year to $21559.0; the TTM figure through Jun 2025 stood at $21559.0 (changed N/A YoY), while the FY2024 annual figure was $45238.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability eased to $21559.0 in Q2 2025 per BDMD's latest filing, from $45238.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $45238.0 in Q4 2024 and bottomed at $21559.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Baird Medical Investment Holdings | 32.80 Mn | 32.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 21,559.00 |
| Jun 30, 2025 | 21,559.00 |
| Dec 31, 2024 | 45,238.00 |
| Dec 31, 2024 | 45,238.00 |